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Anti-hormone-sensitive lipase (HSL) immunoglobulin selectively immunoprecipitates a single 84 kDa 32P-phosphopro- 
tein from macrophage homogenates previously phosphorylated by cyclic AMP-dependent protein kinase in the presence 
of [y-32P]ATP-Mg. This immunoglobulin also completely removes the neutral cholesterol ester hydrolase activity from 
macrophage homogenates. These data demonstrate that HSL is responsible for the neutral cholesterol ester hydrolase 
activity in macrophages and hence plays a key role in cholesterol metabolism in these cells. 
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1. INTRODUCTION 
Macrophages are believed to be precursors of 
the lipid-laden foam cells present in atherosclerotic 
plaques [l]. Macrophages maintained in tissue 
culture can be induced, by incubation with low- 
density lipoprotein, to accumulate large stores of 
esterified cholesterol and take on the appearance 
of foam cells [2]. Furthermore, the cholesterol 
esters in smooth muscle foam cells have been 
shown to be derived from recycled inclusions taken 
up from lysed macrophages [3]. Since the ac- 
cumulation of cholesterol esters in macrophages 
has such implications, it is clearly of great impor- 
tance to elucidate the mechanisms whereby they 
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are stored and mobilized in this cell type. 
Macrophages internalise LDL in endocytotic 
vesicles which are passed onto lysosomes where the 
cholesterol esters are degraded by an acid 
hydrolase. This liberates free cholesterol which 
leaves the lysosome and is either excreted, passing 
to HDL which acts as acceptor, or re-esterified in 
the cytoplasm by ACAT. 
Stored cholesterol ester can be hydrolysed subse- 
quently by a cytoplasmic neutral cholesterol ester 
hydrolase and passed to HDL or, in the absence of 
HDL, the free cholesterol is retained in the cell and 
re-esterified by ACAT; about 50% of the stored 
cholesterol esters are hydrolysed and re-esterified 
each day in this cycle [2]. During conditions of 
cholesterol ester accumulation the rate of 
esterification must clearly exceed that of hydrolysis 
of the esters. 
A neutral cholesterol ester hydrolase activity has 
been demonstrated in cell-free extracts of 
macrophages and shown to be activated by cyclic 
AMP-dependent protein kinase [4], consistent with 
regulation of this enzyme by phosphorylation. It 
has been demonstrated previously that HSL has 
cholesterol ester hydrolase activity [5] and that, in 
addition to its role in lipolysis [6], HSL is responsi- 
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ble for the cholesterol ester hydrolase activity in 
steroidogenic tissues [7,8]; furthermore, its 
cholesterol ester hydrolase activity can be activated 
by cyclic AMP-dependent protein kinase-mediated 
phosphorylation [9]. In this report we present 
direct evidence that HSL is responsible for the 
neutral cholesterol ester hydrolase activity in 
macrophages, providing a possible mechanism for 
hormonal or therapeutic control of intracellular 
levels of cholesterol esters. 
2. MATERIALS AND METHODS 
2.1. Materials 
HSL was purified from bovine perirenal adipose tissue as in 
[lo]. The catalytic subunit of cyclic AMP-dependent protein 
kinase was purified to homogeneity from bovine adipose tissue 
[ 111. Antiserum against bovine adipose tissue HSL was raised 
in a New Zealand White rabbit and an immunoglobulin fraction 
prepared as in [12]. [y-‘*P]ATP was from Amersham Interna- 
tional, hexokinase was from Boehringer, Pansorbin from 
Calbiochem and trypsin (tosyl-phenylalanyl chloromethyl 
ketone treated) from Worthington. Sources of substrates, pro- 
tease inhibitors and the non-ionic detergent CrsE12 were as 
described in [lo]. Fuji RX X-ray film was used for 
autoradiography. 
2.2. Preparation of macrophage homogenate 
The mouse macrophage cell-line WEHI (supplied kindly by 
Dr C.G. Brooks, University of Newcastle upon Tyne) was 
maintained in RPMI-1640 medium (Gibco), containing 10% 
fetal bovine serum (Sigma), 50 U/ml penicillin, 50 pg/ml strep- 
tomycin, 3 mM glutamine and 50 pM 2-mercaptoethanol. Cells 
were harvested by centrifugation at 500 x g for 5 min and the 
cell pellet resuspended at a final concentration of approx. 5 x 
lo6 cells/ml in 5 mM imidazole, pH 7.0, containing 0.1 mM 
benzamidine-HCI, 1 mM dithiothreitol, 30% glycerol, 0.2% 
CrsErs, 50 mM NaCl, 5 #g/ml leupeptin and 1 fig/ml pepstatin. 
The WEHI cells were disrupted by sonicating for 4 x 30 s on 
ice, using an exponential microtip coupled to a Dawe Type 
7533A ultrasonic generator. Cell debris was removed by cen- 
trifugation at 10000 x g for 5 min and the soluble extract used 
fresh or stored at -70°C until use. 
2.3. Enzyme activity 
Neutral cholesterol ester hydrolase activity was assayed at pH 
7.0 against cholesterol [“Hloleate in ethanolic suspension [13]. 
1 unit of activity catalyses the release of 1 /tmol fatty acid per 
min. Protein was determined by the method of Bradford [14]. 
2.4. Phosphorylation of purified HSL and macrophage 
homogenate 
Prior to phosphorylation, purified bovine HSL was trans- 
ferred into 5 mM imidazole-HCl (pH 7.0), containing 1 mM 
dithiothreitol, 30% (w/v) glycerol, 50 mM NaCl, 5 pg/ml 
leupeptin and 1 /g/ml pepstatin [12]. Phosphorylation of the 
purified HSL and macrophage homogenate was performed in 
the presence of 0.1 mM [y-32P]ATP (5000-10000 dpm/pmol), 
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1 mM MgClr and 3 FM catalytic subunit of cyclic AMP- 
dependent protein kinase, as described in [15]. 
2.5. Preparation of immunoprecipitates 
Immunoprecipitates were prepared by incubating either the 
‘*P-phosphorylated purified HSL or macrophage xtract with 
anti-HSL immunoglobulin as in the legend to fig.1, following 
the procedure detailed in [12]. Controls were incubated with 
normal rabbit serum, then treated in an identical manner. The 
immunoprecipitates were analysed by SDS-PAGE [16] followed 
by autoradiography. Tryptic digestion of the immunoprecipi- 
tated 84 kDa phosphoprotein and separation of the 
phosphopeptides by reverse-phase HPLC was carried out as in 
[ 151. The phosphopeptides were also analysed by high-voltage 
electrophoresis at pH 1.9 and autoradiography [12]. 
Non-phosphorylated macrophage homogenate was incubated 
with anti-HSL immunoglobulin as in the legend to fig.2. 
Following treatment with Pansorbin and centrifugation to 
precipitate the immune complexes [12], the supernatants were 
assayed for cholesterol ester hydrolase activity. Controls were 
performed using normal rabbit serum. 
3. RESULTS AND DISCUSSION 
When macrophage xtracts were incubated with 
the catalytic subunit of cyclic AMP-dependent 
protein kinase in the presence of [y-32P]ATP-Mg, 
a large number of polypeptides became 
phosphorylated (fig. 1). Treatment of the phospho- 
rylated extracts with anti-HSL immunoglobulins 
led to immunoprecipitation of a single phosphory- 
lated polypeptide of approx. 84 kDa (fig.l), the 
same size as the HSL polypeptide from several 
other sources [S,lO]. Immunoprecipitation of the 
84 kDa 32P-phosphoprotein was blocked in a com- 
petitive manner by the presence of increasing 
amounts of non-radioactive HSL from adipose 
tissue. The site on adipose tissue HSL which is 
phosphorylated by cyclic AMP-dependent protein 
kinase has recently been characterised and se- 
quenced [ 151; when tryptic phosphopeptides from 
the macrophage 84 kDa 32P-phosphoprotein and 
bovine HSL were subjected to reverse-phase 
HPLC, two major peaks of radioactivity were 
recovered in each case, corresponding in elution 
positions to phosphopeptides Tl and T2 described 
previously [ 151. When the tryptic 32P-phosphopep- 
tides were analysed by high-voltage electrophoresis 
and autoradiography, the same electrophoretic 
pattern was observed for “P-phosphopeptides 
derived from the macrophage 84 kDa protein and 
adipose tissue HSL (results not shown). 
Taken together, the above data strongly support 
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Fig. 1. Immunoprecipitation of phosphoproteins from 32P- 
phosphorylated macrophage extracts. Macrophage extract 
(1OOpg) was incubated for 30 min at 30°C with the catalytic 
subunit of cyclic AMP-dependent protein kinase (3 PM), 1 mM 
MgCls and 0.1 mM [y-‘*P]ATP (5000-10000 dpm/pmol), as 
was purified HSL (1.25 pg). Phosphorylation was terminated 
by the addition of 0.1 vol. of 1 M glucose and 0.01 vol. of 
10 mg/ml hexokinase. Immunoprecipitates (lanes l-5) were 
prepared from the “P-phosphorylated samples using anti-HSL 
immunoglobulin (375 ,ug) [12]; in lanes 3-5, unlabelled adipose 
tissue HSL was added to the ‘*P-labelled macrophage xtract 
prior to addition of anti-HSL immunoglobulin, as indicated. 
Samples were analysed by SDS-PAGE and autoradiography. 
Lanes: 1, adipose tissue HSL; 2, macrophage xtract; 3, 4 and 
5, macrophage xtract + 1.0, 10 and 50 ng unlabelled adipose 
tissue HSL, respectively; 6, ‘*P-phosphorylated macrophage 
extract (25 pg) without immunoprecipitation. 
the conclusion that HSL is present within 
macrophages and suggest hat it may contribute to 
the neutral cholesterol ester hydrolase activity in 
these cells. The neutral cholesterol ester hydrolase 
in WEHI cell extracts was found to have a specific 
activity of 0.7 mU/mg, comparable to values 
reported by Khoo et al. [4]; activity was linear with 
respect to the concentration of protein in the ex- 
tract (not shown). To quantitate the contribution 
of HSL to this activity, anti-HSL immunoglobulin 
was incubated with the extracts and the cholesterol 
ester hydrolase activity assayed in the resultant im- 
munosupernatants. As can be seen in fig.2, the 
cholesterol ester hydrolase activity could be 
precipitated completely by the anti-HSL im- 
Fig.2. Effect of anti-HSL immunoglobulin on the neutral 
cholesterol ester hydrolase activity in WEHI macrophage 
extracts. Macrophage extract (50 ,~l containing approx. 30 fig 
protein) was incubated overnight at 4°C with the indicated 
amounts of anti-HSL immunoglobulin (0) or non-immune 
immunoglobulin (0); all incubations contained the same final 
concentration of protein (400 pg), achieved by the addition of 
an appropriate amount of bovine serum albumin (BSA). The 
immune-complexes were precipitated as in [ 121 and the 
supernatants assayed against cholesterol [‘Hloleate. Activity is 
expressed as a percentage of that observed in the presence of 
400 pg BSA alone. 
munoglobulin, demonstrating that HSL is respon- 
sible for most, if not all, of the neutral cholesterol 
ester hydrolase activity in these extracts. 
Thus, all the data presented here strongly sup- 
port the conclusion that HSL is responsible for the 
neutral cholesterol ester hydrolase activity in 
macrophages. This is consistent with the previous 
observation that this cholesterol ester hydrolase ac- 
tivity is activated by cyclic AMP-dependent pro- 
tein kinase [4]. The ability of the macrophage to 
mobilize cholesterol ester stores may therefore be 
under regulation via the levels of intracellular 
cyclic AMP. The mechanism whereby this activa- 
tion could be facilitated in vivo is unknown, 
however certain agents such as adenosine [17] and 
several prostaglandins, including PGEz and PGI2 
[18], have been reported to increase intracellular 
cyclic AMP levels in macrophages. Raised levels of 
cyclic AMP would be expected to lead to 
phosphorylation of HSL by cyclic AMP- 
dependent protein kinase and potentially to in- 
creased mobilization of macrophage cholesterol 
ester stores due to activation of HSL. However this 
has yet to be demonstrated, but identification of 
the protein responsible for cholesterol ester 
207 
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breakdown in these cells now makes this feasible. 
The recent finding that activation of HSL by cyclic 
AMP-dependent protein kinase can be blocked by 
prior phosphorylation of HSL by the AMP- 
activated protein kinase in vitro [ 191 may also have 
implications for cholesterol metabolism as WEHI 
cells contain significant levels of AMP-activated 
protein kinase (Davies, S., Small, C.A., Yeaman, 
S.J. and Hardie, D.G., unpublished). Clearly it is 
now possible to study regulation of the activity of 
HSL in both normal macrophages and in cells 
loaded with cholesterol esters. 
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